Luke Pater

1.7k total citations
36 papers, 1.2k citations indexed

About

Luke Pater is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Luke Pater has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Luke Pater's work include Glioma Diagnosis and Treatment (11 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Cardiomyopathy and Myosin Studies (7 papers). Luke Pater is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Cardiomyopathy and Myosin Studies (7 papers). Luke Pater collaborates with scholars based in United States, Canada and Greece. Luke Pater's co-authors include Evangelia G. Kranias, Gerald W. Dorn, Kobra Haghighi, Guo‐Chang Fan, Dimitrios Th. Kremastinos, Fotis Kolokathis, Roy A. Lynch, Anthony O. Gramolini, David H. MacLennan and Dimitris Tsiapras and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Luke Pater

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Pater United States 15 769 673 143 116 85 36 1.2k
Rachael A. Vaubel United States 11 469 0.6× 396 0.6× 63 0.4× 186 1.6× 108 1.3× 34 917
John Garcia United States 10 553 0.7× 597 0.9× 102 0.7× 49 0.4× 41 0.5× 16 1.3k
Cemil Özcelik Germany 17 648 0.8× 500 0.7× 115 0.8× 73 0.6× 12 0.1× 24 1.1k
Karin Y. van Spaendonck‐Zwarts Netherlands 22 1.4k 1.8× 847 1.3× 235 1.6× 81 0.7× 52 0.6× 39 2.2k
Barbara McDonough United States 18 1.9k 2.5× 1.7k 2.6× 57 0.4× 138 1.2× 83 1.0× 32 3.0k
Lisa Honold Germany 9 105 0.1× 251 0.4× 40 0.3× 39 0.3× 36 0.4× 11 630
David C. Lee United States 6 118 0.2× 456 0.7× 50 0.3× 23 0.2× 30 0.4× 8 759
Wendy Schaffer United States 11 170 0.2× 198 0.3× 85 0.6× 40 0.3× 35 0.4× 12 645
Belinda Chong Australia 15 118 0.2× 271 0.4× 38 0.3× 79 0.7× 32 0.4× 27 617
Manu Beerens United States 16 86 0.1× 346 0.5× 64 0.4× 44 0.4× 19 0.2× 35 653

Countries citing papers authored by Luke Pater

Since Specialization
Citations

This map shows the geographic impact of Luke Pater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Pater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Pater more than expected).

Fields of papers citing papers by Luke Pater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Pater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Pater. The network helps show where Luke Pater may publish in the future.

Co-authorship network of co-authors of Luke Pater

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Pater. A scholar is included among the top collaborators of Luke Pater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Pater. Luke Pater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benedetti, Daniel J., Nicholas G. Cost, Peter F. Ehrlich, et al.. (2025). Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials. Nature Reviews Urology. 22(11). 775–788.
2.
Sutton, Kathryn S., Amy L. Walz, Andrew J. Murphy, et al.. (2025). Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood & Cancer. 72(8). e31790–e31790.
3.
Pater, Luke, et al.. (2024). Rapid Early Progression after Surgery for IDH-Wildtype Glioblastoma and the Importance of the Pre-Radiation Planning MRI. International Journal of Radiation Oncology*Biology*Physics. 120(2). e268–e269. 1 indexed citations
4.
Carey, Lisa A., et al.. (2023). Safety and Efficacy of Stereotactic Radiosurgery with Concurrent Targeted Systemic Therapy for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 117(2). e107–e107. 1 indexed citations
5.
Lamba, Michael, et al.. (2022). Normal tissue exposure and second malignancy risk in vertebral-body-sparing craniospinal irradiation. Medical dosimetry. 47(2). 142–145. 2 indexed citations
6.
Weiss, Brian, Gregory A. Yanik, Arlene Naranjo, et al.. (2021). A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study. Pediatric Blood & Cancer. 68(10). e29117–e29117. 23 indexed citations
7.
Nagarajan, Rajaram, et al.. (2020). The impact of proton therapy on cardiotoxicity following radiation treatment. Journal of Thrombosis and Thrombolysis. 51(4). 877–883. 8 indexed citations
8.
Fuller, Christine, Trent R. Hummel, Lionel M.L. Chow, et al.. (2020). A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). Journal of Neuro-Oncology. 149(3). 511–522. 29 indexed citations
9.
Pater, Luke, Patrick Melchior, Christian Rübe, et al.. (2020). Wilms tumor. Pediatric Blood & Cancer. 68(S2). e28257–e28257. 30 indexed citations
10.
Pressey, Joseph G., Christopher E. Dandoy, Luke Pater, et al.. (2020). Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult. Gynecologic Oncology. 158(3). 538–546. 9 indexed citations
11.
De, Brian, Luke Pater, John C. Breneman, et al.. (2019). Practice Patterns Among Radiation Oncologists Treating Pediatric Patients With Proton Craniospinal Irradiation. Practical Radiation Oncology. 9(6). 441–447. 5 indexed citations
12.
Warnick, Ronald E., et al.. (2018). Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery. Journal of Neuro-Oncology. 138(2). 335–340. 8 indexed citations
13.
Weber, Damien C., Jean Louis Habrand, Bradford S. Hoppe, et al.. (2018). Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. Radiotherapy and Oncology. 128(1). 44–55. 41 indexed citations
14.
Pater, Luke, Brian Turpin, & Anthony Mascia. (2017). Pencil Beam Scanning Proton Therapy for Rhabdomyosarcoma of the Biliary Tract. Cureus. 9(10). e1747–e1747. 3 indexed citations
15.
16.
Pater, Luke, et al.. (2011). Relationship Between Prostate-specific Antigen, Age, and Body Mass Index in a Prostate Cancer Screening Population. American Journal of Clinical Oncology. 35(5). 490–492. 15 indexed citations
17.
Haghighi, Kobra, Guoli Chen, Yoji Sato, et al.. (2008). A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids. Human Mutation. 29(5). 640–647. 22 indexed citations
18.
Song, Qiujing, Albrecht Schmidt, Harvey S. Hahn, et al.. (2003). Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. Journal of Clinical Investigation. 111(6). 859–867. 93 indexed citations
19.
Haghighi, Kobra, Fotis Kolokathis, Luke Pater, et al.. (2003). Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. Journal of Clinical Investigation. 111(6). 869–876. 353 indexed citations
20.
Schmidt, Albrecht, Jing Zhai, Andrew N. Carr, et al.. (2002). Evaluation of left ventricular diastolic function from spectral and color M-mode Doppler in genetically altered mice. Journal of the American Society of Echocardiography. 15(10). 1065–1073. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachael A. Vaubel Breakdown of academic impact, for papers by John Garcia Breakdown of academic impact, for papers by Cemil Özcelik Breakdown of academic impact, for papers by Karin Y. van Spaendonck‐Zwarts Breakdown of academic impact, for papers by Barbara McDonough Breakdown of academic impact, for papers by Lisa Honold Breakdown of academic impact, for papers by David C. Lee Breakdown of academic impact, for papers by Wendy Schaffer Breakdown of academic impact, for papers by Belinda Chong Breakdown of academic impact, for papers by Manu Beerens
Rankless by CCL
2026